Form 4: NEOGEN Director Converts RSUs to Common Stock

NEOGEN Director Catherine E. Woteki acquired 2,071 shares of common stock through the vesting and settlement of Restricted Stock Units.

Summary

• Catherine E. Woteki, a Director at NEOGEN CORP, reported a transaction on October 7, 2025.
• She acquired 2,071 shares of NEOGEN common stock.
• This acquisition resulted from the vesting and settlement of an equal number of Restricted Stock Units (RSUs).
• The conversion price for these RSUs was $5.63 per unit.
• Following this transaction, Ms. Woteki beneficially owns 15,315 shares of NEOGEN common stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is routine and expected, reflecting a director increasing direct ownership, which is generally viewed favorably as it aligns interests with shareholders. No new operational or financial news is presented.

Positives

• Director Catherine E. Woteki increased her direct ownership in NEOGEN CORP by 2,071 shares, aligning her interests further with shareholders.
• The vesting of Restricted Stock Units indicates the fulfillment of performance or tenure conditions.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction (Form 4) reporting the vesting of equity awards. It does not provide information related to broader industry trends or competitors.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director may be seen as a positive signal of confidence in the company's future.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction involving the vesting and conversion of Restricted Stock Units into common stock by a director. While it indicates continued alignment of management interests with shareholders, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a catalyst for buying or selling.

Keywords

NEOGEN CORP, NEOG, Form 4, Insider Transaction, Restricted Stock Units, RSU, Common Stock, Director, Beneficial Ownership